Zoetis (ZTS) Share-based Compensation (2012 - 2026)

Zoetis' (ZTS) quarterly Share-based Compensation came in at $25.0 million in Q1 2026, up 47.06% year-on-year from $17.0 million in Q1 2025, and up 13.64% on a QoQ basis from $22.0 million in Q4 2025.

Zoetis (ZTS) Share-based Compensation (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Share-based Compensation data on file, last reported at $25.0 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 47.06% year-over-year to $25.0 million in Q1 2026; TTM through Mar 2026 was $91.0 million, a 9.64% increase from a year earlier, with the FY2025 full-year figure at $83.0 million, up 12.16% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $25.0 million, up from $22.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ZTS reached as high as $41.0 million in Q2 2025 and fell as low as $3.0 million in Q3 2025.
  • Historically, Share-based Compensation has averaged $17.9 million across 5 years, with a median of $17.0 million in 2023.
  • On a YoY basis, Share-based Compensation climbed as much as 128.57% in 2022 and fell as far as 78.26% in 2022.
  • Year by year, Share-based Compensation stood at $16.0 million in 2022, then grew by 6.25% to $17.0 million in 2023, then soared by 105.88% to $35.0 million in 2024, then slumped by 37.14% to $22.0 million in 2025, then grew by 13.64% to $25.0 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $25.0 million in Q1 2026, $22.0 million in Q4 2025, and $3.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 7.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.00 Mn
Mar 31, 2026 25.00 Mn
Dec 31, 2025 22.00 Mn
Dec 31, 2025 22.00 Mn
Sep 30, 2025 3.00 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 41.00 Mn
Jun 30, 2025 41.00 Mn
Mar 31, 2025 17.00 Mn
Mar 31, 2025 17.00 Mn
Dec 31, 2024 35.00 Mn
Dec 31, 2024 35.00 Mn
Sep 30, 2024 13.00 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 18.00 Mn
Jun 30, 2024 18.00 Mn
Mar 31, 2024 8.00 Mn
Mar 31, 2024 8.00 Mn
Dec 31, 2023 17.00 Mn
Dec 31, 2023 17.00 Mn